Another negative story/"expose" on clinical trials
in emerging markets airing on DATELINE tonight. What a shame. One
big reason sponsors go to these markets to conduct studies are the need for
more patients to participate. Yet, clearly, conducting trials in these
under-regulated climates is so risky. Until these countries have
established the necessary infrastructure, checks and balances, how about we
just do a better job-recruiting patients in countries with systems "up to
code"? The pool of patients is unquestionably there: Data shows 80% of
those surveyed among the public are interested in participating in clinical
research, yet less than 20% know how or where to get involved. And once they
participate, 80% say they'd do it again! The pool of clinical trial
participants in the U.S. is strong -- we just have to do a better job engaging
and educating people through trusted channels. Starting in April,
MyTrialFinder is taking clinical trials mainstream on WebMD, the most trusted
source for health information online with the largest audience of people
seeking healthcare info. One huge leap closer to solving the problem.
No comments:
Post a Comment